Kreutzburg Thea, Peters Frederik, Kuchenbecker Jenny, Marschall Ursula, Lee Regent, Kriston Levente, Debus E Sebastian, Behrendt Christian-Alexander
Department of Vascular Medicine, Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
BARMER, Wuppertal, Germany.
Eur J Vasc Endovasc Surg. 2021 Feb;61(2):248-256. doi: 10.1016/j.ejvs.2020.11.013. Epub 2020 Dec 15.
Patients with peripheral arterial occlusive disease (PAOD) face an increased risk of both lower limb amputation and death. To date, it has been challenging to predict the long term outcomes for PAOD. The aim was to develop a risk score to predict worse five year amputation free survival (AFS).
In this retrospective analysis of claims data, symptomatic PAOD patients were split into training and validation sets. Variables in the model were patient age and sex, Elixhauser comorbidities, and the 190 most common secondary diagnoses. Penalised Cox regression (least absolute shrinkage and selection operator [LASSO]) with tenfold cross validation for variable selection was performed and patients were categorised into five risk groups using the ten most important variables. All analyses were stratified by intermittent claudication (IC) and chronic limb threatening ischaemia (CLTI).
In total, 87 293 patients with PAOD (female 45.3%, mean age 71.4 ± 11.1 years) were included in the analysis. The most important variable predicting worse five year AFS was patient age >80 years. The GermanVasc score exhibited good predictive accuracy both for IC (c statistic = 0.70, 95% confidence interval [CI] 0.69-0.71) and CLTI (c statistic = 0.69, 95% CI 0.68-0.70) with adequate calibration due largely to alignment of observed and expected risk. Depending on the cumulative point score, the five year risk of amputation or death ranged from 9% (low risk) to 48% (high risk) for IC, and from 25% to 88% for CLTI.
The GermanVasc score predicts worse five year AFS stratified for inpatients suffering from IC and CLTI, with good predictive accuracy. By separating low from high risk patients, the GermanVasc score may support patient centred consent.
外周动脉闭塞性疾病(PAOD)患者面临下肢截肢和死亡风险增加的情况。迄今为止,预测PAOD的长期预后具有挑战性。本研究旨在开发一种风险评分系统,以预测较差的五年无截肢生存期(AFS)。
在这项对索赔数据的回顾性分析中,有症状的PAOD患者被分为训练集和验证集。模型中的变量包括患者年龄、性别、埃利克斯豪泽共病情况以及190种最常见的二级诊断。采用带有十倍交叉验证的惩罚性Cox回归(最小绝对收缩和选择算子[LASSO])进行变量选择,并使用十个最重要的变量将患者分为五个风险组。所有分析均按间歇性跛行(IC)和慢性肢体威胁性缺血(CLTI)进行分层。
总共87293例PAOD患者(女性占45.3%,平均年龄71.4±11.1岁)纳入分析。预测较差五年AFS的最重要变量是年龄>80岁的患者。GermanVasc评分对IC(c统计量=0.70,95%置信区间[CI]0.69 - 0.71)和CLTI(c统计量=0.69,95%CI 0.68 - 0.70)均显示出良好的预测准确性,且校准良好,这主要归因于观察到的风险与预期风险的一致性。根据累积积分,IC患者五年内截肢或死亡风险从9%(低风险)到48%(高风险)不等,CLTI患者则从25%到88%不等。
GermanVasc评分可预测IC和CLTI住院患者较差的五年AFS,预测准确性良好。通过区分低风险和高风险患者,GermanVasc评分可为以患者为中心的知情同意提供支持。